NIH-funded research R01 grant

Evaluating hybrid closed loop therapy for underserved adults with type 1 diabetes

Official title: Effectiveness Trial to Support Adoption of Hybrid Closed Loop Therapy in Underserved Adults with Type 1 Diabetes: Impact of System Functionality and Features on Lived Experience

Funded at Boston Medical Center · NIH-11005063 · Data updated 2026-11-12

This study is looking at how well different types of hybrid closed loop therapy can help adults with type 1 diabetes from underserved communities manage their diabetes and improve their health over nine months.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$854,975
NIH project number5R01DK138309-02
Project IDNIH-11005063 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults with type 1 diabetes, particularly those from underserved communities who may have higher A1c levels and face challenges in diabetes management.

Less likely to help

Patients who do not have type 1 diabetes or those who are not part of underserved communities may not benefit from this research.

What this research studies

This research investigates the effectiveness of hybrid closed loop (HCL) therapy in adults with type 1 diabetes (T1D) from underserved communities. It aims to assess how different HCL systems, which vary in automation and user input, impact diabetes management and overall health outcomes. The study will include a randomized trial with broader eligibility criteria and a longer follow-up period to better understand the benefits and risks of HCL therapy in this population. Participants will be monitored for key health metrics, including blood sugar levels and weight changes, over a nine-month period.

Why it matters

Potential benefit: If successful, this research could lead to improved diabetes management and health outcomes for underserved adults with type 1 diabetes.

How similar studies have gone: Previous research has shown that hybrid closed loop therapy can be effective in more advantaged populations, but this study aims to explore its applicability in underserved groups, making it a novel approach.

Where this research is happening

  • Boston Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Wolpert, Howard a — Boston Medical Center
  • Study coordinator: Wolpert, Howard a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.